Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Abstract Text:

Down syndrome is a major cause of mental retardation and congenital heart defects and is due to the presence of three copies of human chromosome 21 in the affected individual. We have identified a gene, DSCR1 (HGMW-approved symbol), from the region 21q22.1-q22.2, which is highly expressed in human fetal brain and adult heart. Structural features of the conceptual protein encourage us to propose involvement of DSCR1 in the regulation of transcription and/or signal transduction. Higher expression of RNA in the brains of young rats compared to adults suggests a possible role for the gene in the development of the central nervous system. We have determined the genomic organization of DSCR1 and identified three additional alternative first exons by RACE and cDNA library screening. DSCR1 spans nearly 45 kb of genomic DNA and comprises seven exons, four of which (exons 1-4) are alternative first exons. All the exons are flanked by splice junctions that conform to the consensus AG-GT motif. We have studied the expression patterns of the alternative first exons. Exon 2 was detected in fetal brain and liver by RT-PCR. Both exons 1 and 4 were differentially expressed in fetal brain, lung, liver, and kidney and in all adult tissues tested by Northern analysis with two notable exceptions: exon 1 was not detected in adult kidney and exon 4 was not found in adult brain. The high level of expression of exon 1 in fetal brain suggests that this alternative form of DSCR1 has an important role in brain development. This information should help us to understand the possible relationship of DSCR1 with Down syndrome and aid in the development of animal models.

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Publishing Authors By Initials

For similar proteins research abstracts see: proteins research

PUBMED ID PMID:

MEDLINE DATE:

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Genomics

VOLUME: 44

Page Numbers: 358-61

Journal Abbreviation: Genomics

ISSN: 0888-7543

DAY: 15

MONTH: Sep

YEAR: 1997

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8800135

Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Keywords Mesh Terms:

KEYWORDS: Proteins

MESH TERMS: genetics

Chemical & Substance for Abstract: Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Information

Substance Name: RCAN1 protein, human

Registry Number: 0

Grant and Affiliation Information for Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.

AFFILIATION: Molecular Genetics Department, Medical and Molecular Genetics Center-IRO, L'Hospitalet de Llobregat, Barcelona, Spain.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Genomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER: U85267

Number Hits: 0

Genomic organization, alternative splicing, and expression patterns of the DSCR1 Down syndrome candidate region 1 gene Related Publications

• A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
• A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart.
• Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia.
• Alu-splice PCR: a simple method to isolate exon-containing fragments from cloned human genomic DNA.
• Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.
• Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders.
• Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients.
• Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.
• Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa.
• Detection of unrecognized low-level mtDNA heteroplasmy may explain the variable phenotypic expressivity of apparently homoplasmic mtDNA mutations.
• Extensive Genotyping of the BDNF and NTRK2 Genes Define Protective Haplotypes Against Obsessive-Compulsive Disorder.
• Functional genomics of Down syndrome: a multidisciplinary approach.
• Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.
• Identification of two new nonsense mutations (Q311X and W326X) in Exon 2 of the adrenoleukodystrophy (ALD) gene.
• MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene.
• Probe-specific mixed-model approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA).
• Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families.
• Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin.
• [Large-scale genotyping in research into autism spectrum disorders and attention deficit hyperactivity disorder.]